Loading...
Discovery of the first-in-class dual histone deacetylase-proteasome inhibitor
Dual- or multi-target drugs have emerged as a promising alternative to combination therapies. Proteasome inhibitors (PIs) possess synergistic activity with histone deacetylase (HDAC) inhibitors due to the simultaneous blockage of the ubiquitin-degradation and aggresome pathways. Here, we present the...
Na minha lista:
| Udgivet i: | J Med Chem |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6249066/ https://ncbi.nlm.nih.gov/pubmed/30365892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jmedchem.8b01487 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|